First Trust Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-23,900
| Closed | -$423K | – | 2604 |
|
|
2021
Q4 | $423K | Buy |
+23,900
| New | +$423K | ﹤0.01% | 2329 |
|
|
2021
Q3 | – | Sell |
-19,551
| Closed | -$386K | – | 2667 |
|
|
2021
Q2 | $386K | Sell |
19,551
-81,995
| -81% | -$1.62M | ﹤0.01% | 2329 |
|
|
2021
Q1 | $2.95M | Buy |
+101,546
| New | +$2.95M | ﹤0.01% | 1555 |
|
|
2020
Q4 | – | Sell |
-69,009
| Closed | -$1.1M | – | 2437 |
|
|
2020
Q3 | $1.1M | Buy |
+69,009
| New | +$1.1M | ﹤0.01% | 1713 |
|